The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

Meg J Jardine, Kenneth W Mahaffey, Bruce Neal, Rajiv Agarwal, George L Bakris, Barry M Brenner, Scott Bull, Christopher P Cannon, David M Charytan, Dick de Zeeuw, Robert Edwards, Tom Greene, Hiddo J L Heerspink, Adeera Levin, Carol Pollock, David C Wheeler, John Xie, Hong Zhang, Bernard Zinman, Mehul DesaiVlado Perkovic, CREDENCE study investigators, Stefano Genovese

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics'. Together they form a unique fingerprint.

Medicine & Life Sciences